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Background
Infections have been the leading cause of most diseases in the history of mankind (Mon-
dragón et  al. 2014). Especially bacterial infections are more prevailing among these. 
The most common procedure known to fight bacterial infection is through antibiotic 
therapy applied to individuals. The expression of resistance to antimicrobial agents in 
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this therapy is both the logical and indispensable outcome of using these agents to treat 
human infections (Mahmoud and Rice 1999; Ternent et al. 2014).
Resistance developed by the bacteria against antibiotics is described as the talent of 
bacteria to resist the effects of antibiotics generated either to eradicate or control them 
(Arya 2007). The release of each new class of antibiotics for treatment, shortly after, has 
been followed by the emergence of new strains of bacteria which are resistant to this 
class (Butler and Buss 2006; Clatworthy et al. 2007; Lewis 2013). In this respect, develop-
ing new treatment strategies for bacterial infections is very important (Mondragón et al. 
2014).
According to its properties, antibiotics has the bacteriostatic action to stop the growth 
of bacteria and bactericidal action to wipe out the bacteria. However, the distinction 
between these properties is not explicit, as it depends on the drug concentration used 
and the type and the growth stage of bacteria (Zhang 2009). Hence, multiple antibiotic 
therapy is a more appropriate form of treatment.
In fact, the bacterial infection is a complicated process for both the infectious bacteria 
and the host (Carvalho et al. 2012). It is suggested that a significant role in the progress 
of infections is basically played by the immune system (Linares and Martinez 2005). 
The immune system is expressed as a system of biological structures and processes in 
an organism protecting the body from likely harmful substances via recognizing and 
responding to antigens (Alberts et  al. 2002). In this context, the reactions of different 
hosts against the same infection can be different due to immune system’s response given 
by host.
In light of the above, dynamics of relations among antibiotics, immune system’s cells 
and bacteria are important to understand the nature of the infection.
Mathematical models are one of the significant tools used in both analyzing the spread 
of infectious diseases in a population of individuals (Hethcote 2000; Singer 1984), and 
predicting the timing and expansion of infection and possible reinfection processes in 
an individual (Mohtashemi and Levins 2001). While the former is usually used for plan-
ning, prevention and control scenarios, the latter can be active in therapy/intervention 
programs for treating the individuals exposed to the particular pathogen. In this respect, 
understanding and anticipating the time of occurrence and magnitude of the maximum 
load of the bacteria and immune system cells by mathematical modelling can be crucial 
in selecting effective intervention strategies (Whitman and Ashrafiuon 2006).
Consequently, results on reproduction of sensitive and resistant bacteria to antibiot-
ics are obtained in Austin et al. (1997), Bonten et al (2001), Esteva et al. (2011), Wiesch 
et  al. (2011), Zhang (2009); definitions of factors responsible for resistance prevalence 
are studied in Austin and Anderson (1999), Linares and Martinez (2005), Opatowski 
et al. (2011), Rodrigues et al. (2007); bacteria behavior under different antibiotic treat-
ments is examined in Alavez et al. (2006), Bonhoeffer et al. (1997), Bootsma et al. (2012), 
D’Agata et al. (2007), Sun et al. (2010); optimization results and design of control meas-
ures are investigated in Bonten et al. (2001), Haber et al. (2010), Massad et al. (2008), 
Sotto and Lavigne (2012); biological cost and persistence of antibiotic resistance are 
analyzed in Andersson et  al. (2001), Andersson and Levin (1999), Antia et  al. (1996), 
Johnson and Levin (2013), Mondragón et  al. (2014); dynamics between pathogens 
and immune response are given in André and Gandon (2006), Carvalho et  al. (2012), 
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D’Onofrio (2005), Gilchrist and Coombs (2006), Gilchrist and Sasaki (2002), Kostova 
(2007), Mohtashemi and Levins (2001), Nowak and May (2000), Whitman and Ashrafi-
uon (2006), respectively.
In this study, we have constructed a continuous time model considering the immune 
response of the host and the basic mechanisms of bacterial resistance to antibiotics. Our 
aim is to find specific parameters determining the change in the concentrations of the 
immune system’s cells produced in host to fight these and the sensitive sub-populations 
and resistant sub-populations that has either arisen through random mutation and 
clonal enlargement or through cross-contamination in a special infection and under a 
appropriate treatment regimen.
Model formulation
When the emergence of resistant bacteria to antibiotic has modelled, there are the two 
basic aspects generally considered. These are within-host models and within-hospital 
compartmental models. Within-hospital compartmental models are generally SIR mod-
els in epidemiology, considering especially how infections will expand throughout the 
hospital (Ternent et al. 2014). These models are useful to develop strategies to prevent 
the spread of resistant individuals to antibiotic in hospital.
Current mathematical models focusing on the fact that it is within the host that 
resistance develops, aim to study how antibiotic treatment strategies can affect, and in 
addition, how the occurrence of antibiotic resistance can be prevented (Alberts et  al. 
2002; Hethcote 2000). In such models, the effect of immune cells generated by the host 
under the pressure of the bacteria are frequently either neglected or assumed to be at 
a constant rate. We built up the mathematical model including cell-mediated immune 
response. In addition, treatment regimens involving multiple antibiotic have been used 
in most bacterial infections due to bacterial resistant. In this sense, besides the interac-
tion of bacterial-immune response, to investigate the effects of multiple drug therapy is 
biological more meaningful.
We analyzed the concentrations of the immune cells and bacteria in an individual 
receiving a cocktail of multi-drug treatment against bacteria via mathematical model-
ling. Let us denote by S(t) and R(t) the population sizes of sensitive and resistant bacteria 
against multiple antibiotics at time t, respectively, by B(t) population sizes of immune 
cells at time t, and by Ai(t) the concentration of the i-th antibiotic, for i = 1, 2, …, n at 
time t. The parameters used in the model are as follows.
We assume that bacteria follow a logistic growth with carrying capacity T. Let βS and 
(1 − c)βS the birth rate of sensitive and resistant bacteria, respectively. Specific muta-
tions arising from resistance to chemical control frequently have an inherent fitness cost 
which may be resulted through reduced reproductive capacity or competitive ability 
(Alavez et al. 2006). We evaluate fitness cost as a reduction on the reproduction rate of 
the resistant strain, therefore 0 < c < 1. Likewise, we have supposed that using a logistic 
style term, immune cells are recruited to the region of infection at a rate k and carry-
ing capacity of these is as ω fold of amount of present bacteria. This is biologically very 
significant in terms of proliferation of specific immune cells. Also, these interacts can be 
expressed as a generalised model of a local bacterial infection, such as a urinary tract, 
tuberculosis or wound infection.
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During the administration of the i th antibiotic, a number of resistant bacteria to it 
can be showed up due to mutations of exposed sensitive bacteria to such antibiotic, we 
model this situation by the term αiAiS where αi is the mutation rate of sensitive bacteria 
due to exposure to i th antibiotic. Sensitive and resistant bacteria have per capita death 
rates by response of immune cells and this rates is λ. Sensitive bacteria also die due to 
the action of the antibiotics, and we have assumed that this situation in model is by the 
term diAiS, where di is the death rate of sensitive bacteria due to exposure to i-th antibi-
otic. Lastly, the i-th antibiotic concentration is supplied at a constant rate δi, and is taken 
up at a constant per capita rate μi. Under the assumptions a fore mentioned, we obtain 
the following system of (n + 3) ODE’s:
where
To reduce the number of parameters, the variables are changed as follows;
With the new variables, the normalized system is given as;
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(s, r, b, a1, . . . , an) ∈ R
n+3
: 0 ≤ s, r, 0 ≤ b ≤ s + r ≤ 1, 0 ≤ ai ≤ 1, i = 1, . . . , n
}
.
Page 5 of 17Daşbaşı and Öztürk  SpringerPlus  (2016) 5:408 
The following proposition ensures that system (3) is well posed in the sense that the 
solutions with positive initial conditions started in Ω remain in this region for all t ≥ 0, 
and so, this solutions of system (3) have biological meaning.
Proposition 1 The region Ω defined in (4) is positively invariant with respect to the 
system (3).
Proof By adding the first two equations of the system (3),
is obtained. Considering the region Ω, we have the following inequality;
By the solution according to (s + r) of inequality (6), it follows that 0 ≤ s + r ≤ 1 for all 
t ≥ 0. Furthermore, the solutions of the last n equations of system (3) are
where initial conditions satisfy 0  ≤  ai(0)  ≤  1 for i  =  1,  2,  …,  n. Lastly, let 
0 ≤ s + r = u(constant) ≤ 1. Then the solution of third equation in system (3) is
where initial conditions satisfy 0  <  b(0)  ≤  s(0)  +  r(0). From (8), it is obtained that 
0 ≤ b ≤ s + r ≤ 1.
Hence, the vector field of system (3) restricted to the boundary of Ω does not include 
a point at the exterior of it. In this context, solutions starting in Ω+ remain in the region 
Ω for all t ≥ 0.
Qualitative analysis of system (3)
We have examined the existence and stability of equilibria of system (3).
Proposition 2 Let
We accept that the general expressions of the system’s equilibria show as Ej =
(
s¯, r¯, b¯, ai
)
 
for i = 1, 2, . . . , n and j = 0, 1, 2, 3. Then, system (3) always has E0 = (0, 0, 0, 1, 1, …, 1) 
(namely, the infection-free equilibrium point), E1 = (0, 1, 0, 1, 1, …, 1), E2 = (0, B, B, 1, 1, 
…, 1) contained in Ω. When A > B, in addition to E0, E1 and E2, there exists a fourth the 
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Proof In (9), it is clear that
The equilibria of system (3) are given by the solutions of the system of following alge-
braic equations;
From the last n equation of system (11), we have ai = 1 for i = 1, 2, …, n. Consequently, 
the system (11) turns into following system;
From (12), it is obtained that either b¯ = 0 or b¯ = s¯ + r¯.
  • When b¯ = 0, we have that the equilibrium points are E0 = (0, 0, 0, 1, . . . , 1), 
E1 = (0, 1, 0, 1, . . . , 1) and
Although the equilibrium points E0 and E1 always exist in Ω, the equilibrium point EI 
where signs of s¯ and r¯ are opposite, is biologically meaningless. Therefore, EI is not in 
Ω.
  • In case of b¯ = s¯ + r¯, it is obtained the equilibrium points as following;
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(12)
βSs(1− (s + r))− ηsb− s
n∑
i=1
(αi + di) = 0























i=1 αi − βR
∑
n













i=1 αi − βR
∑
n
i=1 (αi + di)
n∑
i=1
αi, 0, 1, . . . , 1
)
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Taking (9) into account, we have that equilibria of system (3) in Ω are
Theorem 3 (Routh–Hurwitz Criteria) Given the polynomial,
where the coefficients ai for i = 1, . . . , n are real constants, define the n Hurwitz matrices 
using the coefficients ai of the characteristic polynomial:
where aj  =  0 if j  >  n. All of the roots of polynomial P(λ) are negative or have nega-
tive real parts, if and only if the determinants of all Hurwitz matrices are positive: 
detHj > 0, j = 1, 2, . . . , n . For polynomial of degree n = 2, 3, 4 and 5, the Routh–Hurwitz 
criteria are summarized.
This criteria has given necessary and sufficient conditions for all of the roots of the 




= F(X) is a nonlinear first-order autonomous system with an 
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satisfies the conditions of the Routh–Hurwitz criteria in Theorem  3, that is, the deter-




> 0, j = 1, 2, . . . , n, then the 




< 0, for some j = 1, 2, . . . , n, 
then the equilibrium X  is unstable (Allen 2007).
The following proposition is shown conditions that equilibrium points in the Proposi-
tion 2 are locally asimptotically stability (LAS).
(13)
E0 = (0, 0, 0, 1, . . . , 1),
E1 = (0, 1, 0, 1, . . . , 1),





A−B+C ,A, 1, . . . , 1
)
, whenA > B.
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Page 8 of 17Daşbaşı and Öztürk  SpringerPlus  (2016) 5:408 
Proposition 4 The equilibrium points of system (3) in Ω satisfy
(i)  E0 and E1 are unstable points.
(ii) If A < B, then E2 is LAS.
(iii) Let B < A, then E3 is LAS.
Proof For the stability analysis, the functions of the right side of system (3) are deter-
mined as follows;
That jacobian matrix obtained from the equations in (14) is
For ease of examination, the τ-th eigenvalue of equilibrium point Ek has shown as λk,τ 
for k = 0, 1, 2, 3 and τ = 1, 2, . . . , n+ 3, n ∈ N .
 (i)  Some of the eigenvalues evaluated at the equilibrium point E0 in Ω are 
0,1 = βS −
∑n
i=1 (αi + di) and λ0,2 = βR. The eigenvalue λ0,2 is positive, due to 
(2). According to Theorem 4, the infection-free equilibrium point E0 is unstable 
point for system (3).
   In the same way, the eigenvalues for E1 in Ω are that 1,1 = −
∑n
i=1 (αi + di), 
λ1,2 = −βR, λ1,3 = k and λ1,i+3 = −μi for i = 1, 2, …, n. The eigenvalue λ1,3 is posi-
tive, due to (2). From Theorem 4, E1 is unstable point for system (3).
 (ii)  The jacobian matrix in (15) evaluated at the equilibrium point E2 in Ω is given 
below 
(14)




















 βS − 2βSs−βSr − ηb−�n
i=1 (αi + di)ai
















(s+r) 0 · · · 0














βS − B(βS + η)−
�n
i=1 (αi + di) 0 0 0 . . . 0
−βRB+
�n
i=1 αi −βRB −ηB 0 . . . 0
k k −k 0 . . . 0







0 0 0 0 . . . −µn

.
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  The eigenvalues of matrix (16) are 2,i+3 = −µi for i = 1, 2, …, n and the remain 
three eigenvalues are found from following matrix;
  where matrix JB(E2) is the block matrix of (16). From (2), it is clear that 
Reλ2,i+3 < 0. Characteristic equation of (17) is
  By the solution of (18), these eigenvalues are determined. Hence, it is obtained 
that
 and λ2,2 and λ2,3 are gained by solving following equation,
  It can be observed that (k + βRB), kβR > 0, due to (2) and (10). From Theorem 3 
(n = 2), Re2,2 and Re2,3 < 0. According to Theorem 4, the LAS conditions for 
E2 are provided for the eigenvalues, 2,i+3, 2,2 and 2,3, exceptionally λ2,1in the 
(19). It is sufficient to examine the sign of λ2,1. By (9), (19) it can be rewrited as 
λ2,1 = (βS + η)(A − B). In this respect, λ2,1 is negative, when A < B.
 As a result, the equilibrium point E2 is LAS for system (3), when A < B.




  The eigenvalues obtained from (21) are λ3,i+3 = −μi for i = 1, 2, …, n and the 
remaining three eigenvalues, λ3,1, λ3,2 and λ3,3, are found from following matrix;
  where the matrix JB(E3) is the block matrix of (21). By (2), it is Reλ3,i+3 < 0. Char-
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s¯, r¯, b¯, 1, 1, . . . , 1
)
for A > B.
(23)JB(E3) =

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 where
 We have a1, a3 > 0 due to (2) and (22). By (25), we have that
and so,
  Therefore, it is obtained that a1a2  −  a3  >  0 due to (2) and (22). From 
Theorem  3(n =  3), Reλ3,1,  Reλ3,2 and Reλ3,3  <  0. According to Theorem  4, The 
equilibrium point E3 in Ω is LAS for the system (3), when it exists biological, that 
is, B < A. Hence, proof is completed.
The LAS conditions found for equilibrium points in (13) are summarized in the 
Table 1.
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Proposition 6 Let us denote by Γ2 the LAS region of the equilibrium point E2 in Ω. In 
the same way, Γ3 is for E3. Then Γ2 ∩ Γ3 = ∅.
Proof It can be clearly observed in Table 1.
The parameter values and it’s references used for numerical study are given in Table 2.
Proposition 7 If A < B, then the equilibrium point E2 =  (0, B, B, 1, …, 1) is globally 
asimptotically stable (GAS) in Ω.
Proof Their solutions approach ai = 1 for i = 1, 2, …, n, when last n equations of sys-
tem (3) are considered separately. Replacing s = 0 and ai = 1 for i = 1, 2, …, n in system 
Table 1 Existence and stability conditions of the equilibria of system (3)
Where the values A, B and C are as indicated in (9)
Equilibrium points Biological existence conditions LAS conditions
E0 = (0, 0, 0, 1, . . . , 1) Always exists Unstable
E1 = (0, 1, 0, 1, . . . , 1) Always exists Unstable








, A, 1, 1, . . . , 1
)
B < A When it exists biological
Table 2 Interpretation and considered values of the parameters
Datas are deduced from the literature
The values obtained from this table are that (i) in the first case, A = 0.260674, B = 0.571428 (A < B) and 
so, E2 = (0, 0.5714, 0.5714, 1, . . . , 1) is LAS. (ii) in the second case, A = 0.334538, B = 0.25 (A > B) and so, 
E3 = (0.3337, 0.0008, 0.3345, 1, 1, . . . , 1) is LAS
Among the treatment regimen recommended by WHO includes isoniazid (INH) and pyrazinamide (PZA) for some bacterial 
infectious (such as Mycobacterium tuberculosis) (Coll 2009)
Parameter Description Value References
βS Growth rate of sensitive bacteria 0.8 day−1 Mondragón et al. (2014)
(1− c)βS ,
0 < c < 1
Growth rate of resistant bacteria 0.4–0.1 day−1 Mondragón et al. 
(2014)-hypothesis
k Growth rate of immune cells 0.6 day−1 Pugliese and Gandolfi 
(2008)
η Rate of bacteria destroyed by  
immune cells
0.3 day−1 Pugliese and Gandolfi 
(2008)
ω Rate to the amount of present bacteria  
of carrying capacity of immune cells
1 Hypothesis
T Carrying capacity of bacteria 109 bacteria Alavez et al. (2006)
α1 Mutation rate of INH 10−6 mut×gen Coll (2009)
α2 Mutation rate of PZA 0 Mondragón et al. (2014)
d1 Elimination rate of sensitive bacteria  
due INH
0.0039 day−1 Zhang (2009)
d2 Elimination rate of sensitive bacteria  
due PZA
0.0001625 day−1 Alavez et al. (2006)
δ1 Daily dose of INH 5 mg/kg/day Coll (2009)
δ2 Daily dose of ZPA 35–20 mg/kg/day Coll (2009)
µ1 Uptake rate of INH 0.06 day−1 Esteva et al. (2011)
µ2 Uptake rate of PZA 0.03 day−1 Esteva et al. (2011)
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(3), we attain the asymptotically equivalent planar system (Mondragón et al. 2014) in the 
region Ω1 = {(r, b) ∊ R2:0 < b ≤ r ≤ 1} given by
According to the Dulac criterion, there exists a continuously differentiable Dulac func-
tion Φ(r, b) for a simply connected region Ω1 ⊂ R2 such that
Since (f(r, b), g(r, b)) is the vector field of system (26),
This result reveals that system (26) has no periodic orbits contained in the interior of 
Ω1 in compliance with Dulac-Bendixon criterion. In addition, the region Γ2 cited in the 
Proposition 6 does not include another the LAS equilibrium point. Thus, by the Poin-
caré–Bendixon Theorem and Dulac–Bendixon criterion, we have that equilibrium point 
E2 = (0, B, B, 1, …, 1) is GAS.
For status (i) obtained from the Table 2, the qualitative analysis of the system (2) has 
supported by numerical simulations in the following Figs. 1, 2 and 3. Here, it is shown 
that the equilibrium point E2 is GAS. Also, as a result of using multiple antibiotics at 
least for 60 days, sensitive bacteria is removed and resistant bacteria and immune cells 






= f (r, b) = βRr(1− r)− ηrb
db
dt










































Fig. 1 In case of (i) in the Table 2, time-dependent changes of all the variables
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Proposition 8 Let B < A. Then,
where the values s¯, r¯ and b¯ are in (22).
Proof Let b < b¯. This shows that b is an increasing function and approach asymptoti-












Let b > b¯. In the same way, b is approaches asymptotically to b¯ by decreasing. Thus, it 
is obtained that b−b¯b
db
dt







Fig. 2 In case of (i) in the Table 2, time-dependent changes of bacteria and immune cells
Fig. 3 In case of (i) in the Table 2, time-dependent changes of bacteria
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Proposition 9 Let A > B. If 1− r¯ < s and A−(1−σ)b
σ
< s + r < A−(1−B)bB , then equilib-
rium point E3 is GAS in the region
where σ = βS
βS+η
.
Proof If the last n equations of system (3) are separated, then their solutions approach 
ai = 1 for i = 1, 2, . . . , n. Replacing these values in the first three equations of system (3), 
we attain the following:
in the region (29). Considering (9), then the system (30) transforms to
where σ = βS
βS+η
. Also, it is clear that σ > A.
In this context, the GAS of equilibrium point E3 can be obtained by applying the 
LaSalle-Lyapunov Theorem. Lyapunov function is
where c1, c2 and c3 are arbitrary positive constants and s¯, r¯ and b¯ are in (22). Differentiat-
ing V (s, r, b) with respect to t, we get
Let 1− r¯ < s. In this case, since 0 < 1− (s¯ + r¯) < s − s¯ and 1− r¯ + r < s + r < 1, it is 
obtained that
respectively. In addition, if A−(1−σ)b
σ
< (s + r) < B−(1−B)bB , then
(29)Ω2 =
{


























= (βS + η)s(A− (s + r)σ − b(1− σ))
dr
dt
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By (34) and (35), we have
From (28) and (36), It is obtained that dVdt < 0. In this respect, if 1− r¯ < s and 
A−(1−σ)b
σ
< s + r < B−(1−B)bB , then equilibrium point E3 is GAS for system (31) in Ω2, 
and so, for system (3) in Ω. Proposition is proved.
For status (ii) obtained from the Table 2, the qualitative analysis of the system (3) has 
supported by numerical simulations in Fig.  4. In this case, it is found that E3 is GAS. 
Moreover, sensitive and resistant bacteria to multiple antibiotics and immune system 
cells have positive equilibrium values as in E3.
Conclusions
In this paper, we formulated a mathematical model of bacterial resistance to immune 
system response and multiple antibiotics simultaneously, considering specific changes 
in bacterial DNA sequence as the only mechanism of bacterial resistance acquisition in 
order to evaluate the effectiveness of antibiotic treatments with respect to the mecha-
nism above.
The parameter A is interpreted as the number of bacteria produced by the fraction of 
sensitive bacteria that survive to the effects due to antibiotics and immune cells. Simi-
larly, the parameter B represents the bacteria produced by resistant bacteria. Also, the 
parameter η is expresses as effect of immune cells on the bacteria .
Our model is quite appropriate when compared to the complexity of biological phe-
nomenon and it predicts in terms of the parameters A and B when the bacterial progres-
sion is either for resistant bacteria and immune cellsas shown in Figs. 1, 2 and 3 or for 
sensitive and resistant bacteria and immune cells as shown in Fig. 4.
The model suggests that if sensitive bacteria can infect but do not produce sufficient 
progeny (in case of A < B) then they can be removed and resistant bacteria continue to 
survive in balance with the immune cells in the host. When sensitive bacteria persist, 












Fig. 4 In case of (ii) in the Table 2, time-dependent changes of all the variables
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enough to eliminate them (in case of A > B), and therefore both types of bacteria con-
tinue to survive and coexist in balance with the immune cells in the host.
According to the results of this analysis, the infection never disappears. Also, the 
infection is continued by resistant bacteria, when the appropriate antibiotics are used, 
otherwise sensitive and resistant bacteria. The magnitude of infection depends on the 
effect of immune system in the first case and multiple antibiotics and immune system in 
the second case.
These results in our model highlight the fact that those whose immunity response 
against infections have diminished, suffer from the same bacterial infections more. Fur-
thermore, this model shows that some of the bacterial infections believed to be limited 
or destroyed, make an individual whose immune system deteriorated suffer more.
Additionally, the results obtained from numerical studies in terms of bacterial infec-
tion reveal the affinity substantially with reference to the clinical treatment.
For future work we are planing consider other mechanisms such as the loss of resist-
ance in the resistant bacteria and gaining resistance by conjugation of sensitive and 
resistant bacteria in order to get more accurate results.
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